Skip to main content
. 2022 Jul 15;9(7):317. doi: 10.3390/bioengineering9070317

Table 1.

Results of the ex vivo experiments.

ET HA [mL] Insertion
Angle
Insertion Side Outflow of HA CBCT/MRI
1 0.3 n/a n/a No
2 1 n/a n/a No
3 0.3 n/a n/a No
4 0.35 30° Aligned No Good
5 0.35 30° Aligned No Good
6 0.35 30° Aligned Yes Good
7 0.4 30° Aligned No Good
8 0.3 45° Aligned No Good
9 0.3 45° Aligned No Good
10 0.4 40° Aligned No Good
11 0.4 40° Central slightly behind the entrance No Too nuchal
12 0.3 40° Aligned Yes Hardly visible
13 0.3 40° Aligned No Good
14 0.3 40° Aligned No Hardly visible
15 0.65 40° Approx. 2 mm further rostral Yes Good with rostral bulge
16 0.3 50° Central slightly behind the entrance No Good
17 0.4 40° Aligned No Good with rostral bulge
18a 0.3 40° Aligned No Good
18b 0.3 + 0.75 40° Aligned No Good with rostral bulge
19a 0.5 40° Aligned No Good
19b 0.5 + 0.5 40° Aligned Yes Good with rostral bulge
20 0.2 40° Approx. 4 mm further rostral No Just rostral of the ET
21a 0.4 40° Aligned No Good
21b 0.4 + 0.2 40° Approx. 2 mm further rostral No Good with a separate depot
rostral
22 1.2 (s) 40° Aligned No Good with rostral bulge (MRI)
23 0.5 (s) 40° Aligned No Good (MRI)

n/a—not applicable (not documented); s—stabilized HA; aligned—position according to Figure 2; good—depot is located according Figure 3. In cases with a/b, the same ET was used for a second injection after a CBCT scan.